Cutaneous Leishmaniasis in an Immigrant Worker: A Clinical Image
Abstract
- CASE PRESENTATION
A 45-year-old adult presented to the PAF Hospital Unit-I with a two-week history of skin lesions on his right foot. Physical examination revealed painless erythematous papules with overlying scaling and crusting, some exhibiting central ulceration.
The patient, a PAF employee, had recently visited Rajanpur, Punjab, where cutaneous leishmaniasis is endemic. He recalled being bitten by sandflies during his stay. Initially, a red, itchy papule developed at the bite site, gradually enlarging into an ulcer. A smear from dermal scrapings, tissue culture, and polymerase chain reaction (PCR) confirmed Leishmania tropica as the infecting agent.
He was admitted to PAF Hospital Unit-I and treated with Meglumine Antimoniate. An intramuscular injection of pentavalent antimony was administered at a dose of 20 mg/kg/day for 28 days, along with an intralesional injection at a dose of 30 mg/day per lesion for 10 days. Complete blanching at the base of the lesion was observed following deep tissue infiltration.
- DISCUSSION
Leishmaniasis is an infectious disease caused by protozoan parasites of the genus Leishmania, transmitted to humans through the bites of infected female sandflies (1). Cutaneous Leishmaniasis (CL) is the most prevalent form of the disease, characterized by the appearance of one or multiple ulcers or nodules at the sites of infectious sandfly bites (2). Early identification and treatment of Cutaneous Leishmaniasis (CL) are crucial to preventing severe complications.
References
1. Malani, P. N. (2010). Mandell, Douglas, and Bennett’s Principles and Practice of Infectious Diseases. JAMA, 304(18). doi:10.1001/jama.2010.1643
2. Goto, H., & Lauletta Lindoso, J. A. (2012). Cutaneous and Mucocutaneous Leishmaniasis. Infectious Disease Clinics of North America, 26(2), 293–307. doi:10.1016/j.idc.2012.03.001
Published
Issue
Section
License
Copyright (c) 2025 Muhammad Hamza, Sara Asif

This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors retain copyright and grant the journal the right of first publication, with the work simultaneously licensed under a CC-BY 4.0 License.